Diagnosis and management of pancreatic cancer in adults: A summary of guidelines from the UK National Institute for Health and Care Excellence
Derek O’Reilly(Manchester Royal Infirmary), John P. Neoptolemos(University of Liverpool), Linyun Fou(National Institute for Health and Care Excellence), Anna Jewell(Heidelberg University), Dawn Elliot(Northumbria Healthcare NHS Foundation Trust), Margred Capel(Hospice UK), Kofi Oppong(Freeman Hospital), Elise Hasler(National Institute for Health and Care Excellence), Susan O’Çonnell(Princess Margaret Hospital for Children), Lesley Goodburn(Heidelberg University), Richard Charnley(Newcastle upon Tyne Hospitals NHS Foundation Trust), Pippa Corrie(University of Cambridge), Ferruccio Pelone(National Institute for Health and Care Excellence), Laura McGeeney(University of Cambridge), Somnath Mukherjee(Churchill Hospital), Fiona Campbell(University of Birmingham), Phil Whelan(University of Liverpool), James Hawkins(University of Bristol), Suzanne Joharchi(Heidelberg University), Mark Callaway(University Hospitals Bristol NHS Foundation Trust), John Primrose(University of Southampton)
Cited by 118
Related Papers
What is meant by intention to treat analysis? Survey of published randomised controlled trials
|BMJ|1999|2.2k
Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial
|The Lancet|2017|1.9k
Effectiveness of brief alcohol interventions in primary care populations
|Cochrane Database of Systematic Reviews|2018|1.7k